Literature DB >> 11182226

MHC haplotypes affect the expression of opportunistic infections in HIV patients.

P Price1, N M Keane, S F Stone, K Y Cheong, M A French.   

Abstract

This study explores whether MHC genes affect manifestations of opportunistic infections in HIV patients not treated with highly active antiretroviral therapy (HAART) and immunopathologic responses to pre-existing infections in patients who achieved immune reconstitution following HAART (i.e., "immune restoration diseases" or IRD). HLA-B27 and B17 were relatively rare in all HIV patients, but no HLA-B alleles significantly affected cytomegalovirus (CMV) or Mycobacterium avium complex (MAC) disease in patients who had not received HAART. However coexpression of alleles previously defined as the 44.1 ancestral haplotype (HLA-A2, -B44, and -DR4) was more common in the MAC and CMV patients. After HAART, HLA-B44 and (HLA-A2, -B44, -DR4) were found in 66% and 33%, respectively, of patients who experienced an IRD manifested as CMV retinitis and/or encephalomyelitis. This was confirmed by examination of microsatellite alleles, where the C1_2_5 locus in the class I region was most concordant with the 44.1 haplotype in the patients. HLA-B44 was not associated with IRD initiated by Mycobacterium sp, cutaneous VZV or HSV, or HCV infections, suggesting distinct pathologic mechanisms are responsible. CMV retinitis/encephalomyelitis IRD patients had marginally lower pretreatment CD4 T-cell counts, but indices of immune reconstitution were similar in all groups and independent of HLA-B44.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11182226     DOI: 10.1016/s0198-8859(00)00239-1

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  12 in total

Review 1.  HIV and asthma, is there an association?

Authors:  Jessica A Kynyk; Jonathan P Parsons; Michael F Para; Susan L Koletar; Philip T Diaz; John G Mastronarde
Journal:  Respir Med       Date:  2012-01-27       Impact factor: 3.415

2.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome.

Authors:  Shuli Bonham; David B Meya; Paul R Bohjanen; David R Boulware
Journal:  Biomark Med       Date:  2008       Impact factor: 2.851

3.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy.

Authors:  Luc Kestens; Nabila Seddiki; Paul R Bohjanen
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

Review 4.  Immune restoration diseases reflect diverse immunopathological mechanisms.

Authors:  Patricia Price; David M Murdoch; Upasna Agarwal; Sharon R Lewin; Julian H Elliott; Martyn A French
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

5.  Invasive pulmonary aspergillosis transformed into fatal mucous impaction by immune reconstitution in an AIDS patient.

Authors:  H Sambatakou; D W Denning
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-09       Impact factor: 3.267

6.  d-Dimer and CRP levels are elevated prior to antiretroviral treatment in patients who develop IRIS.

Authors:  Brian O Porter; G Laissa Ouedraogo; Jessica N Hodge; Margo A Smith; Alice Pau; Gregg Roby; Richard Kwan; Rachel J Bishop; Catherine Rehm; JoAnn Mican; Irini Sereti
Journal:  Clin Immunol       Date:  2010-03-15       Impact factor: 3.969

7.  Illness of Immune Reconstitution: Recognition and Management.

Authors:  Edward M Gardner; Elizabeth Connick
Journal:  Curr Infect Dis Rep       Date:  2004-12       Impact factor: 3.725

8.  An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.

Authors:  N M Keane; P Price; S Lee; S F Stone; M A French
Journal:  Clin Exp Immunol       Date:  2001-10       Impact factor: 4.330

Review 9.  Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy.

Authors:  Martyn A French
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

Review 10.  HIV & immune reconstitution inflammatory syndrome (IRIS).

Authors:  Surendra K Sharma; Manish Soneja
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.